Gynecologic Pathology Diagnosis and Management: Evidence-Based Textbook Covering WHO 2020 Classification, Molecular Subtyping, & FIGO 2023 Staging for ABPath Candidates

Every specimen you sign out in gynecologic pathology is a clinical decision — and the accuracy of that decision determines whether your patient receives the right surgery, the right chemotherapy, or the right conversation with a genetic counselor.A missed STIC on a routine RRSO, a p53 result reported without its pattern, a Krukenberg tumor called a primary ovarian carcinoma — these are not rare edge cases, they are the everyday consequences of pathology practiced without the full morphology-to-management chain in view.This book builds that chain for you, entity by entity, specimen by specimen, so that every result you issue connects directly to a clinical outcome you can defend.• The complete FIGO 2023 endometrial staging framework — apply molecular modifiers, LVSI quantification, and p53abn Stage IIC assignment to every hysterectomy you sign• BRCA/HRD testing that starts in your laboratory — know exactly which results open the olaparib, niraparib, and dostarlimab pathways before the oncologist calls• The MMR IHC reflex algorithm in full — from loss pattern to MLH1 methylation to germline testing recommendation written into your report• Leiomyosarcoma vs. symplastic leiomyoma — the Stanford three-criterion system applied case by case so you stop over-diagnosing and stop missing the real ones• The Translation System built into every chapter — five-part morphology-to-management callouts that take you from H&E to IHC to molecular test to FIGO stage to treatment in a single structured sequence• Primary site determination for every ambiguous mass — Krukenberg, peritoneal mesothelioma, metastatic lobular carcinoma — with the IHC panel that resolves each oneThis book is written for gynecologic pathologists, surgical pathology trainees, and pathology-engaged gynecologic oncologists who want their reports to do more than describe findings. Read more